Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,161.07
(
3.72%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
104.81
(
1.61%
)
Bitcoin
68,060.31
(
-0.30%
)
News Focus
News Focus
Post# of 257323
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mufaso

Send PM Follow Ignore
Followers 42
Posts 697
Boards Moderated 0
Alias Born 01/08/2008

Mufaso

Re: DewDiligence post# 250017

Tuesday, 12/12/2023 3:22:45 PM

Tuesday, December 12, 2023 3:22:45 PM

Post# of 257323
Will do. I will also add Shionogi's S-309309 which has is an MGAT2 inhibitor. It completed ph1 (not much detail available on results there that I can find). There is some detail Shionogi's investor section saying it had promising safety but no info on % of weight loss etc. It is in ph2

https://clinicaltrials.gov/study/NCT05925114?term=%20S-309309&rank=2

Been doing some research to see if I missed anything else of significance and will update when I have run a few more things down.

"People are best convinced by reasons they discover themselves"

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today